What question did this study set out to answer?

This case highlights a rare presentation of lupus enteritis in a young woman with systemic lupus erythematosus (SLE).

Lupus Enteritis Presenting as Acute Abdomen with Clear Gelatinous Stools in a Woman with Systemic Lupus Erythematosus: A Case Report and Literature Review

View Full Paper

Ask AI

Bookmark

Authors

Case report reveals lupus enteritis symptoms in a woman, indicating the need for early diagnosis to prevent complications.

This case highlights a rare presentation of lupus enteritis in a young woman with systemic lupus erythematosus (SLE).
Descriptive case report of a 19-year-old woman with SLE presenting symptoms including abdominal pain and diarrhea.
Laboratory tests and imaging (CT scan) were utilized to identify the cause of gastrointestinal symptoms.
Treatment involved high-dose intravenous methylprednisolone, immunoglobulin, and cyclophosphamide.
Patient presented with clear gelatinous pseudomembrane-like stools, which are uncommon in lupus enteritis.
CT scan showed characteristic findings including small-bowel wall thickening and mesenteric vascular engorgement.
Symptoms improved significantly within 48-72 hours following targeted immunosuppressive treatment.

Wang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Case report reveals lupus enteritis symptoms in a woman, indicating the need for early diagnosis to prevent complications.

This case highlights a rare presentation of lupus enteritis in a young woman with systemic lupus erythematosus (SLE).
Descriptive case report of a 19-year-old woman with SLE presenting symptoms including abdominal pain and diarrhea.
Laboratory tests and imaging (CT scan) were utilized to identify the cause of gastrointestinal symptoms.
Treatment involved high-dose intravenous methylprednisolone, immunoglobulin, and cyclophosphamide.
Patient presented with clear gelatinous pseudomembrane-like stools, which are uncommon in lupus enteritis.
CT scan showed characteristic findings including small-bowel wall thickening and mesenteric vascular engorgement.
Symptoms improved significantly within 48-72 hours following targeted immunosuppressive treatment.

Wang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark